Gum Disease Causes and Risk Factors: Why Some People Are More Susceptible to Periodontitis product guide

AI Summary

Product: Gum Disease Causes and Risk Factors – Why Some People Are More Susceptible to Periodontitis Brand: Smile Solutions Category: Specialist Periodontal Health Information / Clinical Education Guide Primary Use: Explains the bacterial, genetic, systemic, pharmacological, and lifestyle risk factors that determine individual susceptibility to periodontitis, and describes how specialist periodontists use risk assessment in treatment planning.

Quick Facts

• Best For: Adults seeking to understand why periodontitis develops, patients with known risk factors (smoking, diabetes, medications, family history), and those considering specialist periodontal consultation in Melbourne
• Key Benefit: Identifies modifiable and non-modifiable risk factors for periodontitis to enable personalised, risk-stratified specialist treatment planning
• Form Factor: Long-form clinical education article with structured sections, FAQ block, reference list, and summary tables
• Application Method: Read as a pre-consultation or self-education resource; no referral required to book at Smile Solutions (13 13 96)

Common Questions This Guide Answers

1. Is plaque alone enough to cause periodontitis? → No — plaque is necessary but not sufficient; host immune response, genetics, and systemic factors determine disease outcome
2. What is the single largest modifiable risk factor for periodontitis? → Tobacco smoking, with an adjusted odds ratio of 3.97 and 74.8% of periodontitis cases attributable to smoking in NHANES III data
3. Does diabetes increase periodontitis risk, and does the relationship work both ways? → Yes — individuals with diabetes have a 3.1× higher odds ratio for periodontitis, and periodontitis negatively affects glycaemic control; the relationship is bidirectional
4. How much of periodontitis susceptibility is genetically determined? → Up to 50%, with heritability estimates for periodontal bone loss ranging from 0.4 to 0.5
5. Which medications directly affect gingival and periodontal tissue health? → Anticonvulsants (phenytoin), immunosuppressants (cyclosporin), calcium channel blockers (nifedipine), corticosteroids, antidepressants, and bisphosphonates
6. What percentage of Australian adults had moderate or severe periodontitis in 2017–18? → 30%, up from 23% in 2004–06
7. Does smoking cessation reduce tooth loss risk, and how long does it take? → Yes — but a former smoker's tooth loss risk only resembles a never-smoker's after 15 years of abstinence
8. Where is Smile Solutions located and is a referral required? → Manchester Unity Building, 220 Collins Street, Melbourne CBD; no referral required; phone 13 13 96

Frequently Asked Questions

What is periodontitis: A chronic inflammatory disease affecting tooth-supporting structures

Is plaque the only cause of periodontitis: No, plaque is necessary but not sufficient

Can two people with identical plaque levels have different disease outcomes: Yes

What percentage of Australian adults had moderate or severe periodontitis in 2017–18: 30%

What was the Australian periodontitis prevalence in 2004–06: 23%

Is periodontitis prevalence in Australia increasing: Yes

What landmark study showed plaque alone doesn't cause uniform disease: Loë et al. Sri Lankan tea workers study

What percentage of Sri Lankan tea workers showed rapid attachment loss: 8%

What percentage of Sri Lankan tea workers showed no attachment loss despite plaque: 11%

What percentage of Sri Lankan tea workers showed moderate attachment loss: 81%

What is the single largest modifiable risk factor for periodontitis: Tobacco smoking

What is the adjusted odds ratio for periodontitis in smokers vs non-smokers: 3.97

What percentage of periodontitis cases were attributable to smoking in the NHANES III study: 74.8%

Is there a dose-dependent relationship between smoking and periodontitis: Yes

Does more years of smoking increase periodontitis risk: Yes

Does more cigarettes per day increase periodontitis risk: Yes

What was the periodontitis prevalence in smokers aged 19–30: 46%

What was the periodontitis prevalence in non-smokers aged 19–30: 12%

What was the periodontitis prevalence in smokers aged 31–40: 88%

What was the periodontitis prevalence in non-smokers aged 31–40: 33%

Does smoking increase gum inflammation signs like bleeding: No, it suppresses bleeding

Why do smokers often show less bleeding despite worse disease: Smoking suppresses immune surveillance in periodontal pockets

Does smoking cessation reduce tooth loss risk: Yes

How long after quitting does a former smoker's tooth loss risk resemble a never-smoker: After 15 years of abstinence

What is the hazard ratio for tooth loss in current smokers: 2.1

Does diabetes increase periodontitis risk: Yes

What is the odds ratio for periodontitis in individuals with diabetes: 3.1 times higher

Does periodontitis affect diabetes control: Yes, it negatively affects glycaemic control

Is the relationship between diabetes and periodontitis bidirectional: Yes

What is the odds ratio for periodontitis when both diabetes and smoking are present: 4.8 times higher

Is the combined effect of diabetes and smoking on periodontitis additive or synergistic: Synergistic

What biological mechanism links diabetes to periodontitis: Hyperglycaemia-driven pro-inflammatory state

What biological mechanism links smoking to periodontitis: Immunosuppression in periodontal tissues

What percentage of periodontitis susceptibility may be genetically determined: Up to 50%

What is the heritability estimate range for periodontal bone loss: 0.4 to 0.5

Does genetic susceptibility to periodontitis increase at younger ages: Yes

What gene cluster is most reproducibly associated with periodontitis risk: Interleukin-1 (IL-1) gene cluster

What is the pooled odds ratio for IL-1A (−889 C/T) variant and periodontitis: 1.35

What is the pooled odds ratio for IL-1B (+3954 C/T) variant and periodontitis: 1.34

Are structural gene defects also linked to periodontitis: Yes, including collagen and cementum defects

Which syndrome causes severe periodontitis due to structural genetic defects: Papillon-Lefèvre syndrome

Is genetic susceptibility to periodontitis a modifiable risk factor: No

What drug class most commonly causes gingival overgrowth: Anticonvulsants, immunosuppressants, and calcium channel blockers

What percentage of phenytoin patients experience gingival enlargement: 50%

What percentage of cyclosporin patients experience gingival enlargement: 30%

What percentage of nifedipine patients experience gingival enlargement: 20%

Which drug has the highest prevalence of gingival overgrowth: Phenytoin

What causes drug-induced gingival overgrowth biologically: Altered fibroblast metabolism causing excessive extracellular matrix deposition

Do corticosteroids increase periodontitis risk: Yes, by suppressing immune surveillance

Do antidepressants affect periodontal risk: Yes, by causing dry mouth

What is the periodontal risk from dry mouth: Reduced salivary antimicrobial protection

Are bisphosphonates a direct risk factor for periodontitis: No

What complication do bisphosphonates cause relevant to periodontal treatment: Medication-related osteonecrosis of the jaw (MRONJ)

What percentage of adults aged 15–24 have periodontitis: 8.6%

What percentage of adults aged 65 and over have periodontitis: 59%

Does periodontitis prevalence increase with age: Yes

Do hormonal fluctuations affect periodontal risk: Yes

Which hormones influence gingival vascularity and immune response: Oestrogen and progesterone

Does gingival inflammation increase during pregnancy: Yes, even without increased plaque

Does psychosocial stress increase periodontitis risk: Yes

What biological mechanism links stress to periodontitis: Cortisol elevation suppresses immune function

Does socioeconomic status affect periodontitis risk: Yes, lower income correlates with higher prevalence

Is being male a risk factor for severe periodontitis in older Australians: Yes

Is being born overseas a risk factor for severe periodontitis in older Australians: Yes

Does obesity increase periodontal disease risk: Yes

Does osteoporosis increase periodontal disease risk: Yes

Does low dietary calcium and vitamin D increase periodontal disease risk: Yes

What classification system incorporates risk factors into periodontitis grading: 2018 EFP/AAP classification

What smoking level defines Grade C periodontitis: 10 or more cigarettes per day

What HbA1c level defines Grade C periodontitis in diabetics: 7% or higher

Does the tissue destruction in periodontitis come directly from bacteria: No, it comes from the host's dysregulated immune response

What causes alveolar bone loss in periodontitis: Sustained osteoclast activation from unresolved inflammation

Should patients disclose all medications at a periodontal consultation: Yes

Is a referral required to book at Smile Solutions: No

Where is Smile Solutions located: Manchester Unity Building, 220 Collins Street, Melbourne CBD

How many clinicians does Smile Solutions have: 60 or more

How many board-registered specialists does Smile Solutions have: 25 or more

How many patients has Smile Solutions treated: Over 250,000

What phone number can patients use to book at Smile Solutions: 13 13 96

Smile Solutions: Gum Disease Causes and Risk Factors – Why some people are more susceptible to periodontitis

Picture two patients sitting side by side in the dental chair. Both have similar oral hygiene habits, similar plaque levels, similar diets. One has healthy gums. The other has lost significant bone around three teeth and is facing tooth loss before the age of 45. This is not a hypothetical — it is one of the most clinically important and least-understood realities of periodontal medicine. At Smile Solutions, Melbourne's specialist dental centre, this clinical paradox sits at the heart of how our board-registered periodontists approach diagnosis and treatment planning.

Periodontal disease is not universal. Severe forms appear only in a portion of the adult population who show abnormal susceptibility, and understanding why that susceptibility exists is fundamental to both preventing and treating the disease effectively. In Australia, the problem is substantial: in 2017–18, around one-third (30%) of adults aged 15 years and over had moderate or severe periodontitis, up from around one-quarter (23%) in 2004–06. Yet plaque alone does not explain this distribution. The answer lies in a complex interaction of bacterial, genetic, systemic, pharmacological, and lifestyle factors — and the clinical imperative is to identify and manage them all.

The bacterial foundation: why plaque is necessary but not sufficient

Periodontitis is a chronic inflammatory disease caused by a bacterial biofilm (dental plaque) that attacks the supporting apparatus of the teeth, particularly the periodontal ligaments and surrounding bone. The critical distinction, though, is that bacterial plaque is a necessary cause of periodontal disease — but not a sufficient one.

The landmark evidence for this comes from a 15-year longitudinal study by Loë et al. following Sri Lankan tea workers who received no professional dental care and had significant plaque and calculus accumulation. Rapid loss of tooth attachment occurred in only 8% of subjects; 81% showed moderate loss; and 11% showed no attachment loss at all, despite the plaque burden and complete absence of professional care. The same bacterial challenge produced three entirely different disease trajectories — which means the body's biological response to that challenge is the decisive variable.

This finding underpins the modern understanding of periodontitis as a disease of host susceptibility as much as bacterial infection.

Modifiable vs. non-modifiable risk factors: a clinical framework

Before examining individual risk factors, it helps to understand whether they can be changed. This distinction directly shapes how our specialists at Smile Solutions approach treatment planning and risk counselling.

Independent modifiable risk factors for periodontal disease include lifestyle factors such as smoking and alcohol consumption, as well as conditions including diabetes mellitus, obesity, metabolic syndrome, osteoporosis, and low dietary calcium and vitamin D. Genetic factors also play a role, and identifying them allows clinicians to target individuals for prevention and early detection.

Smoking: the single largest modifiable risk factor

Of all lifestyle-related risk factors, tobacco smoking has the most robust and extensively documented evidence base — and it is one of the most consequential things you can address to protect your long-term periodontal health.

A landmark analysis of US National Health and Nutrition Examination Survey (NHANES III) data by Tomar and Asma found a crude odds ratio between smoking and periodontitis of 3.58, rising to 3.97 once adjusted for age, race, ethnicity, income, and education. The relationship was dose-dependent — more cigarettes per day and more years of smoking both increased risk — and the study attributed 74.8% of periodontitis cases to smoking, with both current and former smokers contributing.

Earlier research by Bergström and colleagues, published in the Journal of Periodontology, put clinical numbers to this dose-dependent pattern: among nondiabetic subjects, periodontitis prevalence was markedly higher in current smokers than in never-smokers, both in the 19–30 age group (46% vs. 12%) and the 31–40 age group (88% vs. 33%).

The mechanism is not simply one of poor hygiene. Smoking alters pro/anti-inflammatory cytokine ratios at periodontally affected sites, reducing the pro-inflammatory cytokine proportion — in other words, it suppresses the immune surveillance that would otherwise contain infection. Smokers often present with deeper pockets but less clinical bleeding, a deceptively reassuring sign that masks severe underlying destruction. (For more on recognising these clinical signs, see our guide on Gum Disease Symptoms: How to Recognise the Early and Advanced Warning Signs of Periodontitis.)

Cessation is beneficial, but requires sustained commitment. A hazard ratio for tooth loss of 2.1 was found in current smokers, and a former smoker's tooth loss risk only began to resemble a never-smoker's after 15 years of abstinence — indicating that long-term abstinence, not just quitting, is what reduces risk to baseline. If you smoke, our team can incorporate cessation support into your personalised treatment plan.

Diabetes mellitus: a bidirectional amplifier of periodontal destruction

Periodontal disease and diabetes are interrelated in a bidirectional relationship. Diabetes increases the prevalence, extent, and severity of periodontitis; periodontitis, in turn, negatively affects glycaemic control and the course of diabetes.

The clinical magnitude of this risk is significant. A longitudinal cohort study published in 2024 found that individuals with diabetes had a 3.1 times higher odds ratio for developing periodontitis, and that the combined presence of tobacco use and diabetes worsened outcomes further still — a 4.8 times higher odds ratio for periodontitis compared to neither risk factor.

The biological mechanisms are distinct. Diabetes induces a general pro-inflammatory state through hyperglycaemia; smoking promotes immunosuppression in periodontal tissues. When both are present, smoking appears to amplify the hyperinflammatory effect of diabetes, producing a synergistic result greater than the sum of each factor separately. Smoking and hyperglycaemia also affect the subgingival microbiome in different ways, and when these perturbations intersect, the combined disruption is substantially worse.

This means that poorly controlled Type 2 diabetes combined with smoking is not simply two risks added together — the interaction is synergistic and substantially more destructive than either factor alone.

The bidirectional relationship between diabetes and periodontitis is explored in greater depth in our companion article on Gum Disease and Systemic Health: The Evidence Linking Periodontitis to Heart Disease, Diabetes, and Pregnancy Outcomes.

Genetic susceptibility: why the same bacteria produce different outcomes

Periodontitis is shaped by both genetic and environmental factors. Heritability estimates for periodontal bone loss range between 0.4 and 0.5, with heritability increasing at younger ages. In practical terms, up to half of your susceptibility to bone-destructive periodontitis may be genetically determined — a figure comparable to the heritability of type 2 diabetes.

The genetic architecture of periodontitis centres primarily on immune-regulatory genes. Identified risk genes largely fall into functions linking immune response with tissue repair, including SIGLEC-5, DEFA1, FCERG1, PF4/PPBP/CXCL5, PLG, HMCN2, RSPO4, ROBO2, and CTSC.

Among the most clinically reproducible genetic findings are variants in the interleukin-1 (IL-1) gene cluster — specifically the IL-1A (−889 C/T) and IL-1B (+3954 C/T) variants. A meta-analysis by Dommisch et al. confirmed these polymorphisms as statistically significant risk factors, with pooled odds ratios of 1.35 (95% CI: 1.17–1.56; p < 0.001) and 1.34 (95% CI: 1.18–1.52; p < 0.001), respectively.

Research has focused on genes of immunoregulatory molecules including cytokines, chemokines, membrane surface receptors, and antigen recognition proteins. Cytokines such as IL-1A, IL-1B, IL-6, and IL-10, surface receptors including the Fcγ family, and cyclooxygenase-2 and matrix metalloproteinases are all considered key factors in disease progression.

Not all genetic predispositions involve immune system defects. Structural or developmental defects in collagen, cementum, and epithelium are also significant risk factors — which is why patients with certain connective tissue disorders, including Ehlers-Danlos syndrome and Papillon-Lefèvre syndrome, can present with severe periodontitis at very young ages.

Genetic susceptibility cannot be changed, but identifying it allows our specialist periodontists at Smile Solutions to calibrate monitoring intensity and maintenance frequency accordingly. (See our guide on Periodontal Maintenance: How to Prevent Gum Disease from Returning After Specialist Treatment.)

Medications that alter periodontal risk

Several classes of commonly prescribed medications directly affect gingival and periodontal tissue health — a risk factor that is frequently missed in general dental settings. Sharing your full medication history at your first appointment is an essential part of ensuring thorough, personalised care.

Drug-induced gingival overgrowth

Drug-induced gingival overgrowth (DIGO) is excessive enlargement of gingival tissues caused by the adverse effects of certain systemic medications. The most frequently implicated drug classes are anticonvulsants (phenytoin), immunosuppressants (cyclosporine), and calcium channel blockers, particularly nifedipine and amlodipine.

The prevalence figures are clinically significant: phenytoin has the highest prevalence of gingival overgrowth, affecting an estimated 50% of adults treated with it. Cyclosporin affects approximately 30%, and nifedipine approximately 20%.

DIGO occurs because these drugs alter the metabolism of gingival fibroblasts, leading to excessive extracellular matrix deposition and tissue proliferation. The result is firm, fibrotic gingival tissue that may obscure the teeth, making oral hygiene harder to maintain and increasing the risk of periodontal infection. Two patients on identical doses of the same medication can present with dramatically different gingival responses, because individual susceptibility and genetic predisposition both influence how the tissue responds.

Australian Prescriber notes that gingival enlargement is an under-recognised adverse effect of cyclosporin, phenytoin, and calcium channel antagonists, and that medical practitioners and pharmacists are well placed to advise patients of this possibility and emphasise the importance of good oral hygiene as a preventive measure.

Other medication effects

Beyond gingival overgrowth, several other drug categories can affect your periodontal risk:

• Corticosteroids and immunosuppressants (used in autoimmune conditions or post-transplant): Suppress immune surveillance, allowing bacterial biofilms to establish without adequate host response.
• Antidepressants, antihistamines, and antihypertensives: A significant proportion cause xerostomia (dry mouth), reducing salivary buffering and antimicrobial protection, which accelerates both plaque accumulation and disease progression.
• Bisphosphonates (used in osteoporosis and cancer): Not direct risk factors for periodontitis, but associated with medication-related osteonecrosis of the jaw (MRONJ), which complicates surgical periodontal treatment and must be flagged at your initial consultation.

Please disclose your full medication list at your first periodontal appointment — this is a standard component of the comprehensive medical history review we conduct at Smile Solutions. (See our guide on Your First Periodontist Appointment at Smile Solutions: What to Expect at a Specialist Periodontal Consultation.)

Age, sex, and hormonal influences

The proportion of adults with periodontitis increases markedly with age, from 8.6% in those aged 15–24 to 59% in those aged 65 and over. This reflects cumulative bacterial exposure, age-related immune senescence, and the compounding effect of systemic conditions that accumulate over time.

Hormonal fluctuations also modulate periodontal risk. Oestrogen and progesterone influence gingival vascularity and immune responsiveness, which is why gingival inflammation often increases during puberty, pregnancy, and the menstrual cycle — even without any change in plaque levels. Postmenopausal women face the additional risk of osteoporosis: many systemic risk factors for periodontal disease, including smoking, diabetes, obesity, and osteoporosis in postmenopausal women, are relatively common and can be expected to affect most patients with periodontal disease seen in clinical practice. Our specialists take care to assess how these hormonal changes interact with your overall periodontal risk during your consultation.

Psychosocial stress and socioeconomic factors

Chronic psychological stress is an increasingly recognised risk factor for periodontitis. Stress-induced elevation of cortisol suppresses immune function and alters the inflammatory response to periodontal pathogens. Stress also drives behavioural changes — increased smoking, poor diet, neglected oral hygiene — that compound its direct biological effects.

Poorer oral health is evident in Australians from lower socioeconomic backgrounds, reflecting not only access to care, but the higher burden of smoking, poor nutrition, and chronic stress in lower-income populations. Ageing, being male, being born overseas, low household income, no dental insurance, and current smoking are all significant risk factors associated with severe periodontitis among older Australians.

At Smile Solutions, we believe that rigorous, specialist-level care should be clearly explained and accessible. Our team takes the time to understand your individual situation and work with you on a treatment approach that is both clinically thorough and genuinely supportive.

The immune response variation: why inflammation itself is the problem

A common thread running through all of these risk factors is that they alter the host immune response to bacteria — not simply the bacterial load. The immune function of any individual can be understood as immune fitness: the way the host deals with challenges and perturbations encountered during life, including normal inflammation-resolving mechanisms. Inherited genetic susceptibility forms the intrinsic baseline of that fitness.

Chronic inflammatory diseases are polygenic, and many of them share particular single nucleotide polymorphisms that influence immune fitness. This explains the central clinical paradox of periodontitis: the tissue destruction is not caused directly by bacteria, but by the body's own dysregulated inflammatory response to them. In susceptible individuals, the immune system fails to resolve inflammation efficiently, leading to sustained osteoclast activation and progressive destruction of alveolar bone. Understanding this mechanism is central to why specialist-level diagnosis and care makes such a meaningful difference to long-term outcomes.

How Smile Solutions' specialists use risk factor assessment in your treatment planning

Understanding your individual risk profile is not merely academic — it directly determines the intensity, sequencing, and long-term management of your periodontal treatment. Our approach to comprehensive dental care is built on clinical excellence and a genuine commitment to getting this right for every patient.

At Smile Solutions, board-registered specialist periodontists conduct a thorough risk assessment at your initial consultation that includes:

1. Medical history review — identifying systemic conditions (diabetes, cardiovascular disease, osteoporosis), medications (anticonvulsants, calcium channel blockers, immunosuppressants, bisphosphonates), and family history of tooth loss.
2. Smoking and lifestyle history — quantifying pack-year history and assessing your readiness for cessation support.
3. Periodontal charting and radiographic bone-level assessment — establishing current disease severity and comparing it against the expected severity for your plaque levels (the discrepancy itself is diagnostic of heightened susceptibility).
4. Grading the disease — the 2018 EFP/AAP classification system formally incorporates risk factors into the "Grade" component of diagnosis (Grade A, B, or C), with Grade C indicating rapid progression associated with risk factors such as smoking ≥10 cigarettes/day or HbA1c ≥7% in diabetics.
5. Personalised treatment intensity — patients with multiple compounding risk factors are typically assigned more frequent maintenance intervals and may require more aggressive initial therapy.

This risk-stratified approach is what separates specialist periodontal care from routine dental scaling — and it is the foundation of the personalised treatment we provide from our home in the Manchester Unity Building in Melbourne's CBD. (See our guides on Non-Surgical Gum Disease Treatment and Periodontal Maintenance for how these principles translate into clinical protocols.)

Key takeaways

• Plaque is necessary but not sufficient. Identical bacterial loads produce vastly different levels of destruction depending on the host's immune response, genetics, and systemic health.
• Smoking is the single largest modifiable risk factor, with current smokers facing nearly four times the odds of periodontitis compared to never-smokers, and a dose-dependent relationship between pack-years and disease severity.
• Diabetes and smoking interact synergistically — their combined presence produces a 4.8× higher odds ratio for periodontitis than either factor alone, through distinct but complementary biological mechanisms.
• Genetic susceptibility accounts for 40–50% of heritability for periodontal bone loss, mediated primarily through immune-regulatory gene variants that alter the inflammatory response to periodontal pathogens.
• Medications including calcium channel blockers, anticonvulsants, and immunosuppressants directly alter gingival and periodontal tissue biology, affecting up to 50% of patients taking certain drugs, and must be disclosed at every periodontal consultation.

Conclusion

The question of why some people lose teeth to gum disease while others with identical plaque levels do not is one of the most clinically important questions in periodontal medicine. The answer is a convergence of bacterial, genetic, systemic, pharmacological, and lifestyle forces, each of which modulates the immune response to the bacterial challenge in the gingival sulcus. Many of the systemic risk factors for periodontal disease — smoking, diabetes, obesity, osteoporosis in postmenopausal women — are relatively common and can be expected to affect most patients with periodontal disease seen in clinical practice. Risk factor identification and management has become a core component of care for periodontal patients, not an optional add-on.

For patients in Melbourne, understanding your individual risk profile is the essential first step toward effective management. Smile Solutions' board-registered specialist periodontists are trained to conduct this risk stratification, interpret its clinical implications, and design personalised treatment protocols that address not just the disease that is present, but the biological environment in which it developed. Whether your risk is driven by genetics you cannot change, a medical condition requiring careful coordination, or a lifestyle factor that can be modified, the experienced specialists at Smile Solutions ensure that every variable is identified and managed with an evidence-based, genuinely caring approach.

To learn more about how periodontitis is diagnosed and treated, explore our related guides on What Is Periodontics? The Complete Guide to Gum Disease and Specialist Care, Your First Periodontist Appointment at Smile Solutions, and Gum Disease and Systemic Health: The Evidence Linking Periodontitis to Heart Disease, Diabetes, and Pregnancy Outcomes.

Smile Solutions has been providing specialist periodontal care from Melbourne's CBD since 1993. Situated at the Manchester Unity Building, Level 12 and Tower, 220 Collins Street, Smile Solutions brings together 60+ clinicians — including 25+ board-registered specialists — who have cared for over 250,000 patients across Melbourne and beyond. No referral is required to book a specialist appointment. Call 13 13 96 or visit smilesolutions.com.au to arrange your specialist periodontal consultation.

References

• Australian Institute of Health and Welfare (AIHW). "National Oral Health Plan 2015–2024: Performance Monitoring Report." Australian Government, 2020. https://www.aihw.gov.au/reports/dental-oral-health/national-oral-health-plan-2015-2024

• Ha, D.H., et al. "Periodontal Diseases in the Australian Adult Population." Australian Dental Journal, 2020. https://doi.org/10.1111/adj.12765

• Richter, G.M., & Schaefer, A.S. "Genetic Susceptibility to Periodontitis." Journal of Periodontal Research, 2025. https://doi.org/10.1111/jre.70002

• Genco, R.J. "Risk Factors for Periodontal Disease." Periodontology 2000, 2013. PMID: 23574464

• Dommisch, H., et al. (cited in) Mohammadi, H., et al. "Genetic Testing in Periodontitis: A Narrative Review on Current Applications, Limitations, and Future Perspectives." Genes (MDPI), 2025. https://doi.org/10.3390/genes16111308

• Mason, K.A., et al. "Evaluation of the Combined Effects of Tobacco and Diabetes on Periodontal Health Outcomes in India: A Longitudinal Cohort Study." PMC, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC12156678/

• Teles, R., et al. "A Tale of Two Risks: Smoking, Diabetes and the Subgingival Microbiome." The ISME Journal, 2017. https://doi.org/10.1038/ismej.2017.73

• Tomar, S.L., & Asma, S. "Smoking-Attributable Periodontitis in the United States: Findings from NHANES III." Journal of Periodontology, 2000. (Reviewed by American Academy of Periodontology Literature Review.) https://www.perio.org/research-science/periodontal-literature-review/risk-factors/

• Paranjpe, A.G. "Drug-Induced Gingival Overgrowth." StatPearls (NCBI Bookshelf), 2022. https://www.ncbi.nlm.nih.gov/books/NBK538518/

• Australian Prescriber. "Management of Drug-Induced Gingival Enlargement." Australian Prescriber, 2003. https://australianprescriber.tg.org.au/articles/management-of-drug-induced-gingival-enlargement.html

• Loos, B.G., & Van Dyke, T.E. "The Role of Inflammation and Genetics in Periodontal Disease." Periodontology 2000, 2020. PMID: 32385877

• Botelho, J., et al. "The Bidirectional Relationship between Periodontal Disease and Diabetes Mellitus - A Review." Diagnostics (MDPI), 2023. https://doi.org/10.3390/diagnostics13040681

• Nascimento, G.G., et al. "Prevalence, Extent, and Severity of Periodontitis Among Australian Older Adults: Comparison of Two Generations." PMC, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9786236/

Label Facts Summary

Disclaimer: All facts and statements below are general product information, not professional advice. Consult relevant experts for specific guidance.

Verified Label Facts

No product packaging data, Product Facts table, or manufacturer specification data is present in the content provided. No data provided for machine-readable product specifications.

Practice/Clinic Verifiable Facts (sourced from provider-published information):

• Practice name: Smile Solutions
• Address: Manchester Unity Building, Level 12 and Tower, 220 Collins Street, Melbourne CBD
• Phone number: 13 13 96
• Website: smilesolutions.com.au
• Number of clinicians: 60 or more
• Number of board-registered specialists: 25 or more
• Total patients treated: Over 250,000
• Referral requirement: No referral required to book a specialist appointment
• Operating since: 1993

General Practice Claims

• Smile Solutions is described as "Melbourne's specialist dental centre"
• Specialist periodontists are described as conducting "comprehensive" and "thorough" risk assessments
• Care is described as "world-class," "evidence-based," "genuinely caring," and "personalised"
• The practice is described as offering "state-of-the-art" treatment
• The Manchester Unity Building is described as "historic"
• Smile Solutions' approach is described as differentiating "specialist periodontal care from routine dental scaling"
• The practice is described as bringing together specialists "who have cared for over 250,000 patients across Melbourne and beyond"
• Cessation support is described as something the team "can work with you" to incorporate into a personalised treatment plan
• The practice states it ensures "every variable is identified and managed" for each patient